RavenQuest BioMed Inc.
RVVQF · OTC
7/31/2019 | 4/30/2019 | 1/31/2019 | 10/31/2018 | |
|---|---|---|---|---|
| Revenue | $710 | $653 | $300 | -$141 |
| % Growth | 8.6% | 117.7% | 312.8% | – |
| Cost of Goods Sold | $267 | $784 | -$465 | $44 |
| Gross Profit | $443 | -$131 | -$165 | -$184 |
| % Margin | 62.4% | -20.1% | -55% | 130.5% |
| R&D Expenses | $0 | $80 | $0 | $0 |
| G&A Expenses | $2,020 | $1,660 | $2,285 | $3,497 |
| SG&A Expenses | $2,389 | $1,741 | $2,402 | $3,818 |
| Sales & Mktg Exp. | $369 | $81 | $117 | $320 |
| Other Operating Expenses | -$1,946 | -$1,952 | -$1,637 | -$4,002 |
| Operating Expenses | $443 | -$131 | $765 | -$184 |
| Operating Income | -$2,755 | -$1,934 | -$2,417 | -$10,648 |
| % Margin | -388.2% | -296.1% | -805.6% | 7,551.8% |
| Other Income/Exp. Net | -$369 | -$769 | -$777 | -$12,756 |
| Pre-Tax Income | -$3,124 | -$3,205 | -$3,194 | -$23,404 |
| Tax Expense | $0 | $557 | $0 | $153 |
| Net Income | -$3,124 | -$3,205 | -$3,194 | -$22,826 |
| % Margin | -440.2% | -490.6% | -1,064.6% | 16,188.7% |
| EPS | -0.026 | -0.028 | -0.028 | -0.21 |
| % Growth | 6.1% | 1.8% | 86.5% | – |
| EPS Diluted | -0.026 | -0.028 | -0.028 | -0.21 |
| Weighted Avg Shares Out | 119,646 | 115,092 | 112,860 | 109,318 |
| Weighted Avg Shares Out Dil | 119,646 | 115,092 | 112,860 | 109,318 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $899 | $769 | $777 | $731 |
| Depreciation & Amortization | $804 | $481 | $771 | $1,839 |
| EBITDA | -$1,421 | -$1,955 | -$1,647 | -$20,835 |
| % Margin | -200.2% | -299.3% | -548.9% | 14,776.6% |